Novo Quadruples US Patients Starting Wegovy, Boosts Outlook

  • 📰 BNNBloomberg
  • ⏱ Reading Time:
  • 26 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 14%
  • Publisher: 50%

Canada Headlines News

Canada Latest News,Canada Headlines

Novo Nordisk A/S is shipping four times more crucial introductory doses of its weight-loss drug Wegovy in the US than at the end of last year, the drugmaker said as it raised its profit and sales outlook.

Novo Quadruples US Patients Starting Wegovy, Boosts OutlookBitcoin ETFs Flash Signs of Stress as Discounts Reach RecordsBanking Giants Race to Riyadh as MBS Steps Up Pressure CampaignAsian Stocks to Fall, Yen Steadies After Surge: Markets WrapHuawei Lab Barred by US Regulators as Part of Crackdown on ChinaCredit Suisse Faces $36 Million Korea Short-Sale Fine: ChosunExxon Set to Win FTC Approval for Pioneer Deal on SettlementAsian Stocks to Fall, Yen Steadies After Surge: Markets WrapOil Holds...

6% pace, reflecting an economy pressured by high ratesWhat is changing about Canada's capital gains tax and how does it impact me?Poll suggests half of Canadians have negative opinion of latest Liberal budgetExxon Set to Win FTC Approval for Pioneer Deal on SettlementVenezuela’s Maduro Increases Minimum Wage to $130 Ahead of VoteBrown Students to Dismantle Tents, UNC Arrests: Protest TrackerPhilippines Summons China Envoy After Water Cannon IncidentBillionaires Lutnick, Paulson to Host...

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 83. in CA

Canada Latest News, Canada Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Novo’s Wegovy Aids Heart Failure Patients With Diabetes in StudyWegovy, the blockbuster weight-loss medication from Novo Nordisk A/S, eased heart failure symptoms for patients with diabetes in the latest large trial to support use of the drug to treat health conditions linked to obesity.
Source: BNNBloomberg - 🏆 83. / 50 Read more »

U.S. Senate committee investigates pricing of Novo’s Ozempic and WegovySenator Bernie Sanders sent a letter to Novo’s CEO seeking more information on U.S. prices for the two drugs, which are higher than the prices in other countries
Source: globeandmail - 🏆 5. / 92 Read more »

US Senate committee investigates pricing of Novo's Ozempic and WegovyExplore stories from Atlantic Canada.
Source: SaltWire Network - 🏆 45. / 63 Read more »

US Senate committee investigates pricing of Novo's Ozempic and WegovyExplore stories from Atlantic Canada.
Source: SaltWire Network - 🏆 45. / 63 Read more »

EU Probe Finds No Added Suicide Risk Linked to Novo’s WegovyThe European Union’s drug regulator found no added risk of suicide or self-harm for people taking a popular new class of weight-loss and diabetes medicines that includes Novo Nordisk A/S’s Wegovy and Ozempic.
Source: BNNBloomberg - 🏆 83. / 50 Read more »

Wegovy Access Expands to Millions in US on Medicare, Study FindsMedicare’s recent decision to cover Novo Nordisk A/S’s blockbuster obesity shot Wegovy for heart disease will possibly subsidize the drug for some 3.6 million people, according to a new study from Kaiser Family Foundation.
Source: BNNBloomberg - 🏆 83. / 50 Read more »